We are live on ! Find out more
HIMS icon

Hims & Hers Health

154 hedge funds and large institutions have $643M invested in Hims & Hers Health in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

111% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $4.84M

61% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 33

30% more capital invested

Capital invested by funds: $497M → $643M (+$147M)

11% more funds holding

Funds holding: 139154 (+15)

2.73% more ownership

Funds ownership: 55.27%58% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

Holders
154
Holders Change
+15
Holders Change %
+10.79%
% of All Funds
2.65%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.14%
New
28
Increased
53
Reduced
33
Closed
13
Calls
$10.2M
Puts
$4.84M
Net Calls
+$5.36M
Net Calls Change
+$1.04M
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
26
Catalyst Capital Advisors
New York
$2.52M
Fidelity Investments
27
Fidelity Investments
Massachusetts
$2.41M +$2.6M +431,289 +39,351%
Two Sigma Investments
28
Two Sigma Investments
New York
$2.38M +$583K +96,843 +29%
Mirae Asset Global Investments
29
Mirae Asset Global Investments
South Korea
$2.31M -$23.1K -3,837 -0.9%
LCM
30
Landscape Capital Management
New Jersey
$2.29M +$1.08M +179,007 +77%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.09M +$366K +60,695 +19%
Group One Trading
32
Group One Trading
Illinois
$2M +$234K +38,796 +12%
Voloridge Investment Management
33
Voloridge Investment Management
Florida
$1.89M +$1.81M +300,463 +795%
GCP
34
GSA Capital Partners
United Kingdom
$1.81M +$1.3M +216,583 +200%
CSS
35
Cubist Systematic Strategies
Connecticut
$1.76M +$1.17M +193,647 +158%
FCOMV
36
Foresite Capital Opportunity Management V
California
$1.71M
WP
37
Woodline Partners
California
$1.62M +$1.75M +290,278 New
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.57M +$21.1K +3,500 +1%
Man Group
39
Man Group
United Kingdom
$1.55M +$1.68M +278,570 New
PFO
40
Pathstone Family Office
New Jersey
$1.4M +$1.33M +220,582 +716%
AG
41
Algert Global
California
$1.31M +$825K +136,986 +141%
JAM
42
Jupiter Asset Management
United Kingdom
$1.24M +$1.34M +222,898 New
TC
43
TwinBeech Capital
New York
$1.24M -$112K -18,587 -8%
Goldman Sachs
44
Goldman Sachs
New York
$1.19M +$891K +147,835 +225%
Morgan Stanley
45
Morgan Stanley
New York
$1.17M -$27.3K -4,534 -2%
PP
46
PDT Partners
New York
$1.15M +$1.24M +205,234 New
OQS
47
Occudo Quantitative Strategies
Florida
$1.14M -$166K -27,561 -12%
RA
48
Royce & Associates
New York
$1.12M
Two Sigma Advisers
49
Two Sigma Advisers
New York
$967K +$106K +17,600 +11%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$967K +$121K +20,161 +13%

HIMS Hedge Fund Activity: Q3 2022 in Review

154 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q3 2022, worth a combined $643M — up 30% from $497M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HIMS positions and 13 closed out — a net gain of 15 holders — while 53 added to existing stakes and 33 trimmed.

The largest buyer was Nuveen, adding an estimated $9.05M. The largest seller was J. Goldman & Co, cutting an estimated $6.25M.

  • 154 institutional investors held Hims & Hers Health (HIMS) as of Q3 2022, up from 139 in Q2 2022.
  • Funds reported $643M of Hims & Hers Health stock for Q3 2022, up 30% quarter-over-quarter.
  • 28 funds opened new Hims & Hers Health positions in Q3 2022 and 13 closed out, a net change of +15 holders.
  • The largest Hims & Hers Health buyer in Q3 2022 was Nuveen, an estimated $9.05M added.
  • The largest Hims & Hers Health seller in Q3 2022 was J. Goldman & Co, an estimated $6.25M sold.

Based on aggregated 13F filings for Q3 2022.